Efficacy
Slynd® provides effective pregnancy prevention…1,d
PEARL INDEX1
(95% CI; 2.3, 6.4)
AVOIDED PREGNANCY IN CLINICAL STUDIES1
1.8% BECAME PREGNANT
17 out of 953 females evaluated
HIGH BMI WOMEN INCLUDED IN
CLINICAL TRIAL STUDIES1,d:
Mean BMI 28.5 kg/m2
332 subjects BMI ≥ 30 (35%)
173 females had BMI ≥ 35 (18%)
35 years or younger who were of reproductive potential..

Missed pill window
Slynd® has a flexible 24-hour missed pill window to accommodate her busy life.1,e This provides the
window she needs to take Slynd effectively.



Slynd’s 30-hour elimination half-life helps maintain therapeutic plasma levels.1
eSlynd tablets must be taken every day at the same time of the day. If one active tablet is missed, patients must take the missed tablet as soon as possible.

Safety
Slynd has demonstrated in clinical studies with over 3,400 women that it is a safe oral contraceptive…2
and offers a convenient option for many telemedicine patients.

Slynd does not require a blood pressure check prior to initiation.

No Boxed Warning!

Unlike estrogen containing products, there is no evidence of increased risk of myocardial infarction, cerebral thromboembolism, or venous thromboembolism reported in epidemiological studies for progestin-only products.
39.2% of Slynd clinical study participants had 1 or 2 VTE risk factors1,4:

+ Dosing Regimen, Bleeding Profile, & Drospirenone
Resources
Office Resources
References
- 1. Slynd® package insert.
- 2. Data on file.
- 3. Micronor package insert.
- 4. Kimble T et al. Contraception:X. 2020:10020.
- 5. Parsey KS, Pong A. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception. 2000;61:105-111.
- 6. Muhn P, et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models. Contraception. 1995;51:99-110. B.
- 7. Greer et al. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer. Obstet Gynecol. 2005;105:731-740.
- 8. Louw-du Toit R, et al. Biochem Biophys Res Commun. 2020; 526 (6):466-471.
- 9. Schindler AE, et al. Maturitas 2003;4651:S7-S16.